Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlenveagh Regulatory News (GLV)

Share Price Information for Glenveagh (GLV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.27
Bid: 1.26
Ask: 1.34
Change: -0.02 (-1.52%)
Spread: 0.08 (6.349%)
Open: 1.28
High: 1.28
Low: 1.27
Prev. Close: 1.32
GLV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post Stab Notice - Glenveagh Properties PLC

16 Oct 2017 17:00

RNS Number : 6777T
Credit Suisse Securities (Eur) Ltd
16 October 2017
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A BREACH OF APPLICABLE LAW OR REGULATION.

16 October 2017

 

Glenveagh Properties PLC

 

Exercise of Over-allotment Option and Post-Stabilisation Period Announcement

 

Further to the pre-stabilisation period announcement dated 10 October 2017, Credit Suisse Securities (Europe) Limited ("Credit Suisse") (contact: Lloyd Adams; telephone: +44 20 7888 6341) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) was or will be undertaken by Credit Suisse (as "Stabilisation Manager") in relation to the offer of the following securities:

 

Issuer:

Glenveagh Properties PLC

Guarantor (if any):

N/A

Aggregate nominal amount:

500,000,000 fully paid ordinary shares of €0.001 each

Description:

Initial Public Offering of ordinary shares of €0.001 each

Stabilisation Manager(s):

Credit Suisse Securities (Europe) Limited

Offer price:

€1 per ordinary share

 

On 16th October 2017, Credit Suisse, as Stabilisation Manager, exercised in full the over-allotment option granted by Glenveagh Properties PLC ("Glenveagh") in respect of 50,000,000 ordinary shares in Glenveagh (the "Over-allotment Shares") at the offer price of €1 per Over-allotment Share.

Following the exercise of the over-allotment option, the stabilisation period (initially expected to conclude by 8 November 2017) is hereby terminated as of the date hereof.

Although stabilisation offers were made, no stabilisation transactions were carried out.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of Glenveagh in any jurisdiction.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. This announcement is not an offer to sell or the solicitation of an offer to purchase or subscribe for any securities of the Issuer in the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and may not be offered, sold or resold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offering of securities in the United States.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are "qualified investors" within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be made) and must not be acted on or relied on by other persons in that Member State.

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAOKADQFBDKCKD
Date   Source Headline
28th Jun 20243:21 pmRNSHolding(s) in Company
26th Jun 20244:48 pmRNSNotice of H1 Trading Statement 2024
14th Jun 202410:21 amRNSChanges to Board Committee Composition
4th Jun 20249:30 amRNSHolding(s) in Company
4th Jun 20249:25 amRNSTotal Voting Rights
28th May 20243:06 pmRNSHolding(s) in Company
8th May 20247:00 amRNSAppointment of Joint Corporate Broker
7th May 20243:58 pmRNSHolding(s) in Company
3rd May 20242:15 pmRNSAwards under the Glenveagh Properties plc LTIP
3rd May 20248:48 amRNSHolding(s) in Company
2nd May 20242:58 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Statement
1st May 202410:39 amRNSTotal Voting Rights
29th Apr 20249:23 amRNSDirector/PDMR Shareholding
12th Apr 202412:24 pmRNSHolding(s) in Company
4th Apr 20244:24 pmRNSHolding(s) in Company
2nd Apr 20246:08 pmRNSBlock listing Interim Review
2nd Apr 20244:47 pmRNSDirector/PDMR Shareholding
2nd Apr 20244:44 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:01 amRNSTotal Voting Rights
28th Mar 20245:27 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSBlock Listing Application
25th Mar 202411:57 amRNSTotal Voting Rights
25th Mar 202411:48 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20249:28 amRNSTotal Voting Rights
28th Feb 20247:00 amRNSFinal Results 2023
16th Feb 20249:23 amRNSNotice of Results
1st Feb 202410:56 amRNSTotal Voting Rights
30th Jan 20243:24 pmRNSHolding(s) in Company
29th Jan 20245:28 pmRNSHolding(s) in Company
15th Jan 202412:46 pmRNSHolding(s) in Company
10th Jan 20247:02 amRNSAppointment of Two New Non-Executive Directors
10th Jan 20247:00 amRNSFull Year Trading Statement 2023
5th Jan 202411:45 amRNSHolding(s) in Company
2nd Jan 20249:47 amRNSTotal Voting Rights
15th Dec 20231:42 pmRNSNotice of Full-Year Trading Statement 2023
13th Dec 20236:04 pmRNSHolding(s) in Company
13th Dec 20234:19 pmRNSHolding(s) in Company
12th Dec 20232:47 pmRNSHolding(s) in Company
12th Dec 20239:30 amRNSDirector/PDMR Shareholding
6th Dec 20239:46 amRNSHolding(s) in Company
6th Dec 20239:40 amRNSHolding(s) in Company
5th Dec 202310:58 amRNSHolding(s) in Company
1st Dec 20238:31 amRNSTotal Voting Rights
1st Nov 20239:43 amRNSTotal Voting Rights
31st Oct 20239:08 amRNSHolding(s) in Company
30th Oct 20237:00 amRNSBlock Listing Application
23rd Oct 20234:00 pmRNSDirector/PDMR Shareholding
6th Oct 20232:11 pmRNSHolding(s) in Company
3rd Oct 202312:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.